PDCD1 and neoplasm: In a murine model of CRC orthotopic transplantation, treatment with PLX3397 depleted M2 macrophages in the tumor and induced infiltration of CD8-positive T cells into the tumor, thereby enhancing the efficacy of immunotherapy with anti-PD-1 antibody.